Related Experiment Video

Updated: Aug 6, 2026

The MODS method for diagnosis of tuberculosis and multidrug resistant tuberculosis
23:06

The MODS method for diagnosis of tuberculosis and multidrug resistant tuberculosis

Published on: August 11, 2008

The impact of multiple drug therapy on leprosy disabilities

M L Willcox1

  • 1Keble College, Oxford, UK.

Leprosy Review
|March 21, 1998
PubMed

Insights

Bactericidal drugs may increase short-term reactions but prevent long-term leprosy impairments. Multiple drug therapy (MDT) reduces disease duration and disability, with clofazimine potentially lowering erythema nodosum leprosum (ENL) incidence.

Area of Science:

  • Infectious Diseases
  • Pharmacology
  • Dermatology

Background:

  • Leprosy treatment has evolved, with multiple drug therapy (MDT) becoming standard.
  • Understanding the short- and long-term effects of different treatment regimens is crucial for managing leprosy complications.

Purpose of the Study:

  • To evaluate the impact of bactericidal drugs and MDT on leprosy reactional states and long-term disability.
  • To assess the role of clofazimine within MDT in preventing erythema nodosum leprosum (ENL).

Main Methods:

  • Review of controlled trials on bactericidal drugs in leprosy.
  • Analysis of clinical experience with multiple drug therapy (MDT), focusing on clofazimine's role.

Main Results:

  • Bactericidal drugs increase short-term Type I reactions but prevent long-term impairments from bacterial proliferation.
  • MDT, compared to monotherapy, significantly reduces active disease duration, preventing disability score deterioration.
  • Clinical data suggest clofazimine in MDT reduces Type II reactions/ENL incidence.

Conclusions:

  • MDT is effective in reducing leprosy disease duration and preventing disability progression.
  • Early detection and treatment are key to lowering population disability rates.
  • While MDT offers benefits like improved compliance and motivation, supplementary measures are essential for comprehensive disability prevention and management.

More Related Videos

Optimized Protocols for Mycobacterium leprae Strain Management: Frozen Stock Preservation and Maintenance in Athymic Nude Mice10:32

Optimized Protocols for Mycobacterium leprae Strain Management: Frozen Stock Preservation and Maintenance in Athymic Nude Mice

Published on: March 23, 2014

An Automated Culture System for Use in Preclinical Testing of Host-Directed Therapies for Tuberculosis09:34

An Automated Culture System for Use in Preclinical Testing of Host-Directed Therapies for Tuberculosis

Published on: August 16, 2021

Related Concept Videos

Pulmonary Tuberculosis I01:29

Pulmonary Tuberculosis I

Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Pulmonary Tuberculosis V01:28

Pulmonary Tuberculosis V

Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the progression...
Therapeutic Drug Monitoring: Affecting Factors01:29

Therapeutic Drug Monitoring: Affecting Factors

Therapeutic Drug Monitoring (TDM) is the clinical practice of measuring specific drug levels in a patient's blood or body tissues to manage and optimize therapy. TDM is crucial for drugs with narrow therapeutic windows, like warfarin and phenytoin, where incorrect doses can lead to treatment failure or severe side effects. This monitoring ensures the dosage administered is within a safe and effective range. The factors affecting therapeutic drug monitoring include:Patient-Specific Factors:a.
Effect of Hepatic Disease on Pharmacokinetics: Dose Adjustments Due to Hepatic Impairment01:08

Effect of Hepatic Disease on Pharmacokinetics: Dose Adjustments Due to Hepatic Impairment

Hepatic impairment, characterized by decreased liver function, does not uniformly mandate adjustments in drug dosage. Whether dosage modifications are necessary depends on various factors related to the drug's metabolism and elimination pathways. If a drug is primarily excreted via the kidneys and bypasses significant hepatic processing, if it undergoes minimal metabolic transformation in the liver, or if it is volatile and primarily expelled through the lungs, dose adjustments may not be...
Drug Therapy01:28

Drug Therapy

The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
Antiprotozoal Agents01:21

Antiprotozoal Agents

Leishmaniasis is a widespread parasitic disease caused by several Leishmania species. It affects millions of people each year and remains a major public health problem in endemic regions. First-line treatment relies on pentavalent antimonials, including meglumine antimoniate and sodium stibogluconate. Even so, how these drugs work has not been fully clear, especially their interaction with parasite-specific biochemical pathways. One key target is trypanothione reductase (TR), an enzyme that...